8-K
false 0001428522 0001428522 2020-06-22 2020-06-22

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 22, 2020

 

RADIUS HEALTH, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-35726

 

80-0145732

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

950 Winter Street, Waltham, MA

 

02451

(Address of principal executive offices)

 

(Zip Code)

(617) 551-4000

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, $0.0001 par value per share

 

RDUS

 

The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective June 22, 2020, Joseph Kelly will no longer serve as Senior Vice President of Sales and Marketing of Radius Health, Inc, (the “Company”). The Company expects that Mr. Kelly’s last day of employment with the Company will be July 6, 2020. The Company thanks Mr. Kelly for his contributions to the Company since joining in 2017. In connection with his departure, Mr. Kelly is entitled to receive a lump sum severance payment in an amount equal to nine months of his base salary plus a lump sum payment equal to the COBRA premiums necessary to continue his and his dependents’ health insurance coverage for a period of nine months, in exchange for executing and delivering to the Company a General Release of Claims, substantially in the form included as an exhibit to the form of Executive Severance Agreement filed with the Securities and Exchange Commission on March 1, 2018. The foregoing description of the terms and conditions of Mr. Kelly’s separation is only a summary and is qualified in its entirety by the full text of such form of Executive Severance Agreement.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

RADIUS HEALTH, INC.

             

Date: June 22, 2020

 

 

By:

 

/s/ Kelly Martin

 

 

Name:

 

Kelly Martin

 

 

Title:

 

President and Chief Executive Officer

v3.20.1
Document and Entity Information
Jun. 22, 2020
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001428522
Document Type 8-K
Document Period End Date Jun. 22, 2020
Entity Registrant Name RADIUS HEALTH, INC.
Entity Incorporation State Country Code DE
Entity File Number 001-35726
Entity Tax Identification Number 80-0145732
Entity Address, Address Line One 950 Winter Street
Entity Address, City or Town Waltham
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02451
City Area Code (617)
Local Phone Number 551-4000
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.0001 par value per share
Trading Symbol RDUS
Security Exchange Name NASDAQ
Entity Emerging Growth Company false